Search All News
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.
- March 26, 2018
On average, patients see more than eight physicians before being diagnosed with a mitochondrial disease, a new CUIMC study finds.
- March 23, 2018
A stroke education program that uses hip hop music increased stroke awareness among economically disadvantaged minority children and their parents.
- January 30, 2018
Researchers from two Columbia University campuses have teamed up to develop a football helmet that detects concussion in real time.
- January 24, 2018
Clinical trial shows that solanezumab, an antibody-based treatment for Alzheimer’s disease, does not significantly slow cognitive decline.
- January 16, 2018
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
- November 22, 2017
New video that reveals how immune cells breach the blood-brain barrier is giving scientists new ideas about treating multiple sclerosis.
- November 17, 2017
Researchers at Columbia University found that dementia is on the decline in seniors from northern Manhattan, following national trends.
- November 13, 2017
A new study suggests a smell test can identify people with mild cognitive impairment–often a precursor to Alzheimer’s–who may benefit from cholinesterase inhibitors.